Stocks of the Hour: Linius Technologies, Biotron, Elixir Energy
Stocks of the Hour: Linius Technologies, Biotron, Elixir Energy
To register for today's webinar click here.
要注册今天的网络研讨会，请单击此处。
Linius Technologies Ltd (ASX:LNU) has signed a second US college conference and its first deployment in American football. The agreement is to provide its Whizzard sports solution to the Lone Star Conference (LSC). The LSC is the first customer to deploy Linius Media Solutions for American Football. The agreement is for an initial 3 year term. Linius CEO, James Brennan said "We are excited to be working with the LSC, the premier NCAA Division II conference. As our first customer deployment for American football, it provides an important entry into the most highly monetised sport in the US. Unleashing the value of football archives is a top priority for Linius." Shares are trading flat at 0.2 cents.
Linius Technologies Ltd（澳大利亚证券交易所股票代码：LNU）已经签署了第二届美国大学会议，这是它在美式足球领域的首次部署。该协议旨在为孤星联盟（LSC）提供其Whizzard体育解决方案。LSC是第一个为美式足球部署Linius媒体解决方案的客户。该协议的初始期限为3年。莱尼乌斯首席执行官詹姆斯·布伦南表示：“我们很高兴能与LSC合作，这是NCAA第二分区的顶级会议。作为我们在美式足球领域的首次客户部署，它为进入美国收入最高的体育项目提供了重要入口。释放足球档案的价值是Linius的当务之急。”股价持平至0.2美分。
Biotron Limited (ASX:BIT) has annouced preliminary analyses of data from the BIT225-010 Phase 2 clinical trial of the Company's lead antiviral drug BIT225 provide confirmation, and extension, of the results of previous trials in people infected with HIV-1. Study participants were followed for a one month period following 24-weeks of BIT225 or placebo dosing; all individuals continued on cART as per standard treatment guidelines post-study. The primary objectives of the trial were to evaluate the safety, efficacy and impact of BIT225 administered with cART on selected inflammatory and immune markers in this patient population. Shares are trading 22.67 per cent higher at 9.2 cents.
Biotron Limited（澳大利亚证券交易所股票代码：BIT）宣布，对该公司主要抗病毒药物 BIT225 的 BIT225-010 二期临床试验数据的初步分析证实并扩展了先前针对 HIV-1 感染者的试验结果。在 BIT225 或安慰剂给药 24 周后，对研究参与者进行了为期一个月的随访；根据研究后的标准治疗指南，所有个体都继续服用 cART。该试验的主要目标是评估与 cART 一起使用的 BIT225 对该患者群体中选定的炎症和免疫标志物的安全性、有效性和影响。股价上涨22.67％，至9.2美分。
Elixir Energy (ASX:EXR) has provided an operations update on its 100% owned Grandis project located in Queensland, adjacent to the Wallumbilla gas hub. Following a recent successful suite of Diagnostic Formation Integrity Tests conducted at Daydream-2, the Company decided to test the free-flowing capacity of the Lorelle Sandstone between 4,200 and 4,217 metres. The test has been highly successful – with a maximum rate of 2.3 Million Standard Cubic Feet Per Day and stabilised flow rate of 1.3 Million Standard Cubic Feet Per Day. Elixir understands this is the deepest unstimulated flow of gas in onshore Australia East of the Perth Basin. Shares are trading 29.58 per cent higher at 9.2 cents.
Elixir Energy（澳大利亚证券交易所股票代码：EXR）提供了其100％控股的Grandis项目的最新运营情况，该项目位于昆士兰州，毗邻瓦伦比拉天然气枢纽。继最近在Daydream-2成功进行了一系列诊断形成完整性测试之后，该公司决定测试洛雷尔砂岩在4,200至4,217米之间的自由流动能力。该测试非常成功——最大流量为每天230万标准立方英尺，稳定流速为每天130万标准立方英尺。Elixir知道这是珀斯盆地以东澳大利亚陆上最深的未受刺激的天然气流。股价上涨29.58％，至9.2美分。
